Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of Vonoprazan-based triple therapy against Helicobacter pylori infection: A single-center experience with 1118 patients

Published:2016-07-21 Issue:5 Volume:9 Page:747-748
ISSN:1756-2848
Container-title:Therapeutic Advances in Gastroenterology
language:en
Short-container-title:Therap Adv Gastroenterol

Author:

Fukuda Daisuke¹,Akazawa Yuko²,Takeshima Fuminao³,Nakao Kazuhiko³,Fukuda Yutaka¹

Affiliation:

1. Fukuda Yutaka Surgery Clinic, Nagasaki City, Japan

2. Division of Gastroenterology and Hepatology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8562, Japan

3. Division of Gastroenterology and Hepatology, Nagasaki University Hospital, Nagasaki, Japan

Publisher

SAGE Publications

Subject

Gastroenterology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1756283X16654499

Reference4 articles.

1. Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis

2. Vonoprazan: First Global Approval

3. Efficacy of vonoprazan-based second-lineHelicobacter pylorieradication therapy in patients for whom vonoprazan-based ﬁrst-line treatment failed

4. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy forHelicobacter pylorieradication: a phase III, randomised, double-blind study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of Helicobacter pylori Eradication Therapy in Patients 80 Years or Older Living in a Metropolitan Area: A Multicenter Retrospective Study;Helicobacter;2024-07

2. Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy;Antibiotics;2020-09-26

3. Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases;Journal of Neurogastroenterology and Motility;2018-07-30

4. Successful eradication ofHelicobacter pyloriwith a herbal medicine,goshuyuto(Wu Zhu Yu Tang), plus rabeprazole after failure of triplet therapy with vonoprazan: A report of three cases;Journal of Digestive Diseases;2018-03-25

5. Review: A Japanese population-based meta-analysis of vonoprazan versus PPI forHelicobacter pylorieradication therapy: Is superiority an illusion?;Helicobacter;2017-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3